Pancreatic ductal adenocarcinoma (PDAC) is characterized by a highly aggressive phenotype and limited therapeutic options, primarily attributable to diagnostic delays and intrinsic chemotherapy resistance, thereby underscoring the critical need for the development of more effective therapeutic strategies. Tripterine (T...
Li-Rui Tang, Yi Lin, Xue-Qin Jiang et al.· MedComm· 0 citations
Metastatic cancer remains a major clinical challenge, which is driven by the continuous adaptation of disseminated tumor cells to diverse tissue environments and therapeutic pressures. Although current treatments, including conventional therapies, small-molecule drugs, antibody-drug conjugates, and immunotherapies, hav...
H. Ye, Yu-Quan Wei, Xue-Mei He et al.· Journal of Hematology & Onco...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.